
### [NCIT:C3786](http://purl.obolibrary.org/obo/NCIT_C3786)
**Label:** Mesothelial Neoplasm

**Subclasses:** [NCIT:C7985](http://purl.obolibrary.org/obo/NCIT_C7985) (Epithelioid Mesothelioma), [NCIT:C6536](http://purl.obolibrary.org/obo/NCIT_C6536) (Peritoneal Multicystic Mesothelioma), [NCIT:C7866](http://purl.obolibrary.org/obo/NCIT_C7866) (Recurrent Malignant Mesothelioma), [NCIT:C48319](http://purl.obolibrary.org/obo/NCIT_C48319) (Adrenal Gland Adenomatoid Tumor), [NCIT:C136374](http://purl.obolibrary.org/obo/NCIT_C136374) (Pleural Malignant Mesothelioma by AJCC v7 Stage), [NCIT:C6747](http://purl.obolibrary.org/obo/NCIT_C6747) (Desmoplastic Mesothelioma), [NCIT:C136403](http://purl.obolibrary.org/obo/NCIT_C136403) (Stage III Pleural Malignant Mesothelioma AJCC v8), [NCIT:C3234](http://purl.obolibrary.org/obo/NCIT_C3234) (Mesothelioma), [NCIT:C136406](http://purl.obolibrary.org/obo/NCIT_C136406) (Stage IV Pleural Malignant Mesothelioma AJCC v8), [NCIT:C7633](http://purl.obolibrary.org/obo/NCIT_C7633) (Peritoneal Mesothelioma), [NCIT:C136400](http://purl.obolibrary.org/obo/NCIT_C136400) (Stage I Pleural Malignant Mesothelioma AJCC v8), [NCIT:C7635](http://purl.obolibrary.org/obo/NCIT_C7635) (Well Differentiated Papillary Mesothelioma), [NCIT:C136402](http://purl.obolibrary.org/obo/NCIT_C136402) (Stage II Pleural Malignant Mesothelioma AJCC v8), [NCIT:C7354](http://purl.obolibrary.org/obo/NCIT_C7354) (Peritoneal Adenomatoid Tumor), [NCIT:C27926](http://purl.obolibrary.org/obo/NCIT_C27926) (Asbestos-Related Malignant Mesothelioma), [NCIT:C7632](http://purl.obolibrary.org/obo/NCIT_C7632) (Pericardial Mesothelioma), [NCIT:C7631](http://purl.obolibrary.org/obo/NCIT_C7631) (Pericardial Malignant Mesothelioma), [NCIT:C6382](http://purl.obolibrary.org/obo/NCIT_C6382) (Epididymal Adenomatoid Tumor), [NCIT:C4282](http://purl.obolibrary.org/obo/NCIT_C4282) (Biphasic Mesothelioma), [NCIT:C45655](http://purl.obolibrary.org/obo/NCIT_C45655) (Sarcomatoid Mesothelioma), [NCIT:C9253](http://purl.obolibrary.org/obo/NCIT_C9253) (Recurrent Pericardial Malignant Mesothelioma), [NCIT:C126331](http://purl.obolibrary.org/obo/NCIT_C126331) (Ovarian Adenomatoid Tumor), [NCIT:C27250](http://purl.obolibrary.org/obo/NCIT_C27250) (Uterine Corpus Adenomatoid Tumor), [NCIT:C3765](http://purl.obolibrary.org/obo/NCIT_C3765) (Multicystic Mesothelioma), [NCIT:C136399](http://purl.obolibrary.org/obo/NCIT_C136399) (Pleural Malignant Mesothelioma by AJCC v8 Stage), [NCIT:C3762](http://purl.obolibrary.org/obo/NCIT_C3762) (Adenomatoid Tumor), [NCIT:C4499](http://purl.obolibrary.org/obo/NCIT_C4499) (Pleural Adenomatoid Tumor), [NCIT:C45661](http://purl.obolibrary.org/obo/NCIT_C45661) (Peritoneal Well Differentiated Papillary Mesothelioma), [NCIT:C4456](http://purl.obolibrary.org/obo/NCIT_C4456) (Malignant Mesothelioma), [NCIT:C45660](http://purl.obolibrary.org/obo/NCIT_C45660) (Pleural Well Differentiated Papillary Mesothelioma), [NCIT:C45663](http://purl.obolibrary.org/obo/NCIT_C45663) (Pleural Sarcomatoid Mesothelioma), [NCIT:C45662](http://purl.obolibrary.org/obo/NCIT_C45662) (Pleural Epithelioid Mesothelioma), [NCIT:C45665](http://purl.obolibrary.org/obo/NCIT_C45665) (Pleural Biphasic Mesothelioma), [NCIT:C45664](http://purl.obolibrary.org/obo/NCIT_C45664) (Pleural Desmoplastic Mesothelioma), [NCIT:C40129](http://purl.obolibrary.org/obo/NCIT_C40129) (Fallopian Tube Adenomatoid Tumor), [NCIT:C45666](http://purl.obolibrary.org/obo/NCIT_C45666) (Localized Pleural Malignant Mesothelioma), [NCIT:C9350](http://purl.obolibrary.org/obo/NCIT_C9350) (Peritoneal Malignant Mesothelioma), [NCIT:C9351](http://purl.obolibrary.org/obo/NCIT_C9351) (Pleural Mesothelioma), [NCIT:C40444](http://purl.obolibrary.org/obo/NCIT_C40444) (Ovarian Malignant Mesothelioma), [NCIT:C6648](http://purl.obolibrary.org/obo/NCIT_C6648) (Stage III Pleural Malignant Mesothelioma AJCC v7), [NCIT:C6647](http://purl.obolibrary.org/obo/NCIT_C6647) (Stage II Pleural Malignant Mesothelioma AJCC v7), [NCIT:C8707](http://purl.obolibrary.org/obo/NCIT_C8707) (Recurrent Pleural Malignant Mesothelioma), [NCIT:C8705](http://purl.obolibrary.org/obo/NCIT_C8705) (Recurrent Peritoneal Malignant Mesothelioma), [NCIT:C6649](http://purl.obolibrary.org/obo/NCIT_C6649) (Stage IV Pleural Malignant Mesothelioma AJCC v7), [NCIT:C9239](http://purl.obolibrary.org/obo/NCIT_C9239) (Localized Malignant Mesothelioma), [NCIT:C6646](http://purl.obolibrary.org/obo/NCIT_C6646) (Stage I Pleural Malignant Mesothelioma AJCC v7), [NCIT:C92187](http://purl.obolibrary.org/obo/NCIT_C92187) (Pericardial Adenomatoid Tumor), [NCIT:C7376](http://purl.obolibrary.org/obo/NCIT_C7376) (Pleural Malignant Mesothelioma), [NCIT:C8420](http://purl.obolibrary.org/obo/NCIT_C8420) (Diffuse Malignant Mesothelioma), 

**Class expressions from DL-Learner:**

- [CL:0000077](http://purl.obolibrary.org/obo/CL_0000077) (mesothelial cell) and (not ([CL:0002625](http://purl.obolibrary.org/obo/CL_0002625) (seminiferous tubule epithelial cell))) 66.67%
- [CL:0000077](http://purl.obolibrary.org/obo/CL_0000077) (mesothelial cell) and (not ([CL:0000630](http://purl.obolibrary.org/obo/CL_0000630) (supportive cell))) 66.67%
- [CL:0000077](http://purl.obolibrary.org/obo/CL_0000077) (mesothelial cell) and (not ([CL:0000511](http://purl.obolibrary.org/obo/CL_0000511) (androgen binding protein secreting cell))) 66.67%
- [CL:0000077](http://purl.obolibrary.org/obo/CL_0000077) (mesothelial cell) and (not ([CL:0000216](http://purl.obolibrary.org/obo/CL_0000216) (Sertoli cell))) 66.67%
- [CL:0000077](http://purl.obolibrary.org/obo/CL_0000077) (mesothelial cell) and (not ([CL:0000154](http://purl.obolibrary.org/obo/CL_0000154) (protein secreting cell))) 66.67%
- [CL:0000077](http://purl.obolibrary.org/obo/CL_0000077) (mesothelial cell) and (not ([CL:0000151](http://purl.obolibrary.org/obo/CL_0000151) (secretory cell))) 66.67%
- [CL:0000077](http://purl.obolibrary.org/obo/CL_0000077) (mesothelial cell) and (not ([CL:0000068](http://purl.obolibrary.org/obo/CL_0000068) (duct epithelial cell))) 66.67%
- [CL:0000077](http://purl.obolibrary.org/obo/CL_0000077) (mesothelial cell) and (not ([BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity))) 66.67%
- [CL:0000077](http://purl.obolibrary.org/obo/CL_0000077) (mesothelial cell) 52.02%
- [CL:0000077](http://purl.obolibrary.org/obo/CL_0000077) (mesothelial cell) and (not ([CHEBI:23019](http://purl.obolibrary.org/obo/CHEBI_23019) (carbonyl group))) 52.02%
- [CL:0000077](http://purl.obolibrary.org/obo/CL_0000077) (mesothelial cell) and (not ([CHEBI:23004](http://purl.obolibrary.org/obo/CHEBI_23004) (carbamoyl group))) 52.02%
- [CL:0000077](http://purl.obolibrary.org/obo/CL_0000077) (mesothelial cell) and (not ([CHEBI:22868](http://purl.obolibrary.org/obo/CHEBI_22868) (bile salt))) 52.02%
- [CL:0000077](http://purl.obolibrary.org/obo/CL_0000077) (mesothelial cell) and (not ([CHEBI:22563](http://purl.obolibrary.org/obo/CHEBI_22563) (anion))) 52.02%
- [CL:0000077](http://purl.obolibrary.org/obo/CL_0000077) (mesothelial cell) and (not ([CHEBI:17089](http://purl.obolibrary.org/obo/CHEBI_17089) (glycoprotein))) 52.02%
- [CL:0000077](http://purl.obolibrary.org/obo/CL_0000077) (mesothelial cell) and (not ([CHEBI:16990](http://purl.obolibrary.org/obo/CHEBI_16990) (bilirubin))) 52.02%


